Skip to main content
K

KIM FOREST ENTERPRISE CO., LTD. — Investor Relations & Filings

Ticker · 6645 TW Professional, scientific and technical activities
Filings indexed 22 across all filing types
Latest filing 2026-04-30 Regulatory Filings
Country TW Taiwan
Listing TW 6645

About KIM FOREST ENTERPRISE CO., LTD.

https://www.kimforest.com

Kim Forest Enterprise Co., Ltd. specializes in precision medicine and molecular diagnostics, providing integrated solutions for clinical research and healthcare. The company offers a "One Stop Solution" encompassing experimental consultation, laboratory equipment supply, and bioinformatics analysis. Key products and services include Next-Generation Sequencing (NGS), PCR systems, ELISA readers, and high-content imaging systems. The company focuses on genetic testing for cancer screening, hereditary diseases, and personalized health management. By synthesizing genomic data with clinical insights, Kim Forest facilitates biomarker identification and the development of optimized treatment strategies. Its portfolio also extends to customized enzymes, drug screening technologies, and precision nutrition, supporting the advancement of personalized medicine through comprehensive technical expertise and reliable diagnostic reporting.

Recent filings

Filing Released Lang Actions
公告本公司115年第一季財務報告董事會 預計召開日期為115年05月08日
Regulatory Filings
2026-04-30 Chinese
114年第4季財務報告書 — 202504_6645_AIC.pdf
Regulatory Filings
2026-04-21 Chinese
114年第4季財務報告書 — 202504_6645_AIA.pdf
Regulatory Filings
2026-04-21 Chinese
114年第4季財務報告書 — 202504_6645_AI3.pdf
Regulatory Filings
2026-04-21 Chinese
114年第4季財務報告書 — 202504_6645_AI1.pdf
Regulatory Filings
2026-04-21 Chinese
114年第4季財務報告書 — 202503_6645_AI1.pdf
Regulatory Filings
2026-04-21 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.